Byotrol PLC Board Changes (7478N)

TIDMBYOT

RNS Number : 7478N

Byotrol PLC

27 September 2023

Byotrol plc

("Byotrol" or the "Company")

Board Changes

Byotrol Plc (AIM: BYOT), the specialist infection prevention and control company, announces that Vivan Pinto, CEO of the Company, has stepped down as CEO and left the Company to pursue other opportunities.

David Traynor formerly Byotrol CEO 2013 - 2022 has kindly agreed to act as interim CEO until a suitable replacement for Vivan is appointed.

Trevor Francis, Chairman of Byotrol, commented :

"From the time that Vivan took over from David Traynor as CEO, he was committed to drive forward the Company strategy and build the organisation for the exciting opportunities that we all believe are achievable. The Board thanks Vivan for all his efforts over the last 20 months and would like to wish Vivan well for the future".

Enquiries:

 
 Byotrol Plc 
 Trevor Francis - Chairman 
  David Traynor - CEO                                      +44 (0)1925 742 000 
 Chris Sedwell - Chief Financial Officer 
 
 Cavendish Capital Markets Limited (Nominated 
  Adviser and Broker)                                      +44 (0)20 7220 0500 
 Geoff Nash / George Dollemore - Corporate 
  Finance 
 Nigel Birks / Harriet Ward - ECM 
 
 Flagstaff Strategic and Investor Communications           +44 (0)20 7129 1474 
 Tim Thompson/Andrea Seymour/Fergus Mellon          byotrol@flagstaffcomms.com

This announcement is released by Byotrol Plc and, prior to publication, the information contained herein was deemed to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014. Such information is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

For more information, go to byotrol.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAFLFITAFIRFIV

(END) Dow Jones Newswires

September 27, 2023 02:00 ET (06:00 GMT)

Byotrol (LSE:BYOT)
過去株価チャート
から 12 2024 まで 1 2025